ASH 2019 | Next steps for CAR-T in ALL
Stephan Grupp, MD, PhD, Children’s Hospital of Philadelphia, Philadelphia, PA, shares his opinion on what should now be the focus of CAR-T research in acute lymphoblastic leukemia (ALL). Dr Grupp highlights the need for longer follow-ups, extending the reach of CAR-T therapies, and improvements in manufacturing. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.
Get great new content delivered to your inboxSign up